Difference between carbohydrate antigen 19‐9 and fluorine‐18 fluorodeoxyglucose positron emission tomography in evaluating the treatment efficacy of neoadjuvant treatment in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma: Results of a dual‐center study

BACKGROUND: An accurate evaluation of neoadjuvant treatment is important to maximize the prognostic benefit of this strategy in each individual patient. The main aim of the present study is to investigate the difference between carbohydrate antigen 19‐9 and fluorine‐18 fluorodeoxyglucose positron em...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Gastroenterol Surg
Main Authors: Akita, Hirofumi, Takahashi, Hidenori, Eguchi, Hidetoshi, Asukai, Kei, Hasegawa, Shinichiro, Wada, Hiroshi, Iwagami, Yoshifumi, Yamada, Daisaku, Tomimaru, Yoshito, Noda, Takehiro, Gotoh, Kunihito, Kobayashi, Shogo, Doki, Yuichiro, Sakon, Masato
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164457/
https://ncbi.nlm.nih.gov/pubmed/34095729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12418
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados